Rapid Micro Biosystems Inc (RPID)
0.83
+0.01
(+1.05%)
USD |
NASDAQ |
May 14, 16:00
0.83
0.00 (0.00%)
After-Hours: 17:30
Rapid Micro Biosystems Enterprise Value: -44.33M for May 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 13, 2024 | -44.33M |
May 10, 2024 | -45.25M |
May 09, 2024 | -45.03M |
May 08, 2024 | -45.39M |
May 07, 2024 | -42.67M |
May 06, 2024 | -41.96M |
May 03, 2024 | -41.39M |
May 02, 2024 | -37.10M |
May 01, 2024 | -39.67M |
April 30, 2024 | -37.36M |
April 29, 2024 | -38.29M |
April 26, 2024 | -39.07M |
April 25, 2024 | -38.88M |
April 24, 2024 | -39.72M |
April 23, 2024 | -39.78M |
April 22, 2024 | -42.26M |
April 19, 2024 | -41.45M |
April 18, 2024 | -42.73M |
April 17, 2024 | -39.31M |
April 16, 2024 | -39.52M |
April 15, 2024 | -37.86M |
April 12, 2024 | -38.92M |
April 11, 2024 | -37.26M |
April 10, 2024 | -38.45M |
April 09, 2024 | -37.17M |
Date | Value |
---|---|
April 08, 2024 | -37.17M |
April 05, 2024 | -36.75M |
April 04, 2024 | -37.81M |
April 03, 2024 | -38.46M |
April 02, 2024 | -38.04M |
April 01, 2024 | -38.45M |
March 31, 2024 | -38.03M |
March 28, 2024 | -50.54M |
March 27, 2024 | -49.98M |
March 26, 2024 | -50.44M |
March 25, 2024 | -50.41M |
March 22, 2024 | -50.83M |
March 21, 2024 | -50.64M |
March 20, 2024 | -50.42M |
March 19, 2024 | -51.19M |
March 18, 2024 | -50.41M |
March 15, 2024 | -50.41M |
March 14, 2024 | -49.66M |
March 13, 2024 | -50.26M |
March 12, 2024 | -51.57M |
March 11, 2024 | -50.41M |
March 08, 2024 | -50.36M |
March 07, 2024 | -50.45M |
March 06, 2024 | -49.56M |
March 05, 2024 | -49.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-68.40M
Minimum
Aug 09 2023
1.179B
Maximum
Aug 05 2021
102.25M
Average
-38.04M
Median
Enterprise Value Benchmarks
Ainos Inc | 10.59M |
OpGen Inc | 13.31M |
Zomedica Corp | 53.94M |
LENSAR Inc | 20.21M |
Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -13.32M |
Revenue (Quarterly) | 5.611M |
Total Expenses (Quarterly) | 19.88M |
EPS Diluted (Quarterly) | -0.31 |
Gross Profit Margin (Quarterly) | -27.14% |
Profit Margin (Quarterly) | -237.4% |
Earnings Yield | -145.8% |
Normalized Earnings Yield | -145.78 |